When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. List of countries by antidepressant consumption - Wikipedia

   en.wikipedia.org/wiki/List_of_countries_by...

   The source for the data below is the OECD Health Statistics 2018, released by the OECD in June 2018 and updated on 8 November 2018. [1]The unit of measurement used by the OECD is defined daily dose (DDD), defined as "the assumed average maintenance dose per day for a drug used on its main indication in adults". [2]

3. Epidemiology of depression - Wikipedia

   en.wikipedia.org/wiki/Epidemiology_of_depression

   The epidemiology of depression has been studied across the world. Depression is a major cause of morbidity and mortality worldwide, as the epidemiology has shown. [ 1 ] Lifetime prevalence estimates vary widely, from 3% in Japan to 17% in India.

4. Antidepressant - Wikipedia

   en.wikipedia.org/wiki/Antidepressant

   According to National Institute for Health and Care Excellence (NICE) guidelines, antidepressants for children and adolescents with depression and obsessive-compulsive disorder (OCD) should be prescribed together with therapy and after being assessed by a child and adolescent psychiatrist. However, between 2006 and 2017, only 1 in 4 of 12–17 ...

5. FDA-approved nasal spray for severe depression can lead to ...

   www.aol.com/fda-approved-nasal-spray-severe...

   The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

6. FDA approves standalone use of J&J’s ketamine-derived ... - AOL

   www.aol.com/news/fda-approves-standalone-j-j...

   The ketamine-derived drug was first approved in 2019 to be used in combination with antidepressants, and later for patients experiencing suicidal thoughts or actions. ... according to the National ...

7. FDA recalls thousands of antidepressant bottles due to ... - AOL

   www.aol.com/fda-recalls-thousands-antidepressant...

   The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine belongs to a ...